GINA 2023: key changes in the new document

Abstract

ABSTRACT. An update to the Global Initiative for Asthma (GINA) report released this May includes new scientific information on bronchial asthma. This overview presents the main changes in the latest version of the report. The key changes include the clarification of terminology regarding drugs for the treatment of asthma, including the meaning of the terms “maintenance treatment” and “controller medication”; inclusion of a combination of an inhaled corticosteroid and a short-acting β-agonist in the asthma treatment algorithm for adults and adolescents; update of the treatment algorithm for children aged 6-11 years and clarification of the treatment algorithm for children aged ≤5 years; addition of environmental considerations for inhaler choice; updated advice on definition of mild asthma and guidance on managing severe asthma; new practical guide to management of asthma exacerbations; addition of a small section on the use of imaging studies in the asthma diagnosis. GINA calls on international respiratory societies to collaborate with colleagues, patients and medical institutions to promote the development and implementation of effective asthma management programs in all resource countries. Providing access to effective and well-studied drugs, as well as treatment of asthma according to modern step-by-step GINA algorithms, can reduce the burden of asthma on the planet.

Keywords

• gina
• bronchial asthma
• inhaled corticosteroids
• formoterol